INVESTORS > Overview

banner-investor

CORPORATE PROFILE

Kips Bay Medical, Inc. was founded in 2007 to develop innovative vascular technology for the cardiac surgeon. We are a medical device company currently focused on manufacturing and commercializing a compelling technology, the eSVS Mesh, which is an external support device for saphenous veins used as bypass conduits in coronary artery bypass grafting (CABG) surgery.

The Kips Bay Medical eSVS Mesh is designed to address the limitations of saphenous vein grafts, or SVGs, used in CABG surgery. The eSVS Mesh is fitted like a sleeve on the outside of the saphenous vein grafts to strengthen SVGs used in CABG surgery. By strengthening the SVG and preventing the damaging expansion of the vein graft, Kips Bay hopes to reduce or prevent the resulting injury which can lead to SVG failure and potentially costly and complicated re-interventions for the patients undergoing CABG surgery. This innovative design is also intended to ensure that blood flow is faster and more laminar by reducing the diameter mis-match between the SVG and target artery.

CABG is one of the most commonly performed cardiac surgeries in the United States. In 2010, there were 395,000 CABG surgeries in the United States alone, and there were estimated to be 165,000 CABG procedures in Europe in 2013. There are, on average, 2+ saphenous vein grafts used per patient.

STOCK QUOTE

KIPS (Common Stock)
PriceChange% ChangeVolume
$0.21 + 0.015.00%32,510
Exchange: NASDAQ (US Dollar)
10/30/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

RECENT PRESS RELEASES

DateTitle 
10/14/14Kips Bay Medical Provides Clinical and Business Update
MINNEAPOLIS, Oct. 14, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provides an update on its clinical progress and business operations. Enrollment Begins in the Czech Republic On September 30, 2014, the first implant of an eSVS Mesh in the Czech Republic was performed at the H... 
Printer Friendly Version
09/15/14Kips Bay Medical Announces Trading on OTCQB Marketplace
MINNEAPOLIS, Sept. 15, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today announced that its common stock began trading on the OTCQB Marketplace on September 12, 2014. Operated by the OTC Markets Group Inc., the OTCQB is a market tier available to OTC traded companies that are registere... 
Printer Friendly Version
08/25/14Kips Bay Medical Receives Updated CE Mark Approval
MINNEAPOLIS, Aug. 25, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today announced that it has received an updated CE Mark approving use of a new surgical implant technique for its eSVS Mesh. Feasibility Study Update On August 20, 2014, the Company received an updated CE Mark appro... 
Printer Friendly Version
08/12/14Kips Bay Medical Provides Feasibility Study Update and Reports Second Quarter 2014 Results
MINNEAPOLIS, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its second quarter ended June 28, 2014. Enrollment Begins at Lenox Hill Hospital in New York The Company recently announced that on July 17, 2014,... 
Printer Friendly Version
More >>

ANNUAL REPORT

Download Documentation 2013 Annual Report (Proxy Statement and Form 10-K)

CORPORATE PROFILE
Kips Bay Medical, Inc. was founded in 2007 to develop innovative vascular technology for the cardiac surgeon. We are a medical device company currently focused on manufacturing and commercializing a compelling technology, the eSVS Mesh, which is an external support device for saphenous veins used as bypass conduits in coronary artery bypass grafting (CABG) surgery.

The Kips Bay Medical eSVS Mesh is designed to address the limitations of saphenous vein grafts, or SVGs, used in CABG surgery. The eSVS Mesh is fitted like a sleeve on the outside of the saphenous vein grafts to strengthen SVGs used in CABG surgery. By strengthening the SVG and preventing the damaging expansion of the vein graft, Kips Bay hopes to reduce or prevent the resulting injury which can lead to SVG failure and potentially costly and complicated re-interventions for the patients undergoing CABG surgery. This innovative design is also intended to ensure that blood flow is faster and more laminar by reducing the diameter mis-match between the SVG and target artery.

CABG is one of the most commonly performed cardiac surgeries in the United States. In 2010, there were 395,000 CABG surgeries in the United States alone, and there were estimated to be 165,000 CABG procedures in Europe in 2013. There are, on average, 2+ saphenous vein grafts used per patient.